Structure-activity relationships in the acronycine and benzo[b]acronycine series: Role of the pyran ring

European Journal of Medicinal Chemistry

Volumn 43, Issue 12, 2008, Pages 2677-2687

  Do, Quyên ^a   Thi Mai, Huong Doan ^a   Gaslonde, Thomas ^a   Pfeiffer, Bruno ^b   Léonce, Stéphane ^b   Pierré, Alain ^b   Michel, Sylvie ^a   Tillequin, François ^a   Dufat, Hanh ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Acridone; Acronycine; Benzo b acridone; Cytotoxicity

Indexed keywords

1,2 DIACETOXY 1,2 DIHYDROACRONYCINE; 1,2 DIACETOXY 1,2 DIHYDROBENZO[B]ACRONYCINE; 2 (4 ACETOXYMETHYL 5 METHYL 1 METHOXY 12 OXO 5,12 DIHYDROBENZO[B]ACRIDIN 3 OXY) 2 METHYLPROPYL ACETATE; ACRONINE; PYRAN; S 23906 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

ACRONINE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 56949100558     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.01.033     Document Type: Article

References (34)

1. Hughes G.K., Lahey F.N., Price J.R., and Webb L.J. Nature 162 (1948) 223-224
2. Macdonald P.L., and Robertson A.V. Aust. J. Chem. 19 (1966) 275-281
3. Tillequin F., Michel S., and Skaltsounis A.-L. In: Pelletier S.W. (Ed). Alkaloids: Chemical and Biological Perspectives, vol. 12 (1998), Elsevier, Amsterdam 1-102
4. Svoboda G.H. Lloydia 29 (1966) 206-224
5. Svoboda G.H., Poore G.A., Simpson P.J., and Boder G.B. J. Pharm. Sci. 55 (1966) 759-768
6. Scarffe J.H., Beaumont A.R., and Crowther D. Cancer Treat. Rep. 67 (1983) 93-94
7. Brum-Bousquet M., Mitaku S., Skaltsounis A.-L., Tillequin F., and Koch M. Planta Med. 54 (1988) 470-471
8. Elomri A., Mitaku S., Michel S., Skaltsounis A.-L., Tillequin F., Koch M., Pierré A., Guilbaud N., Léonce S., Kraus-Berthier L., and Rolland Y. Gh. Atassi. J. Med. Chem. 39 (1996) 4762-4766
9. Costes N., Le Deit H., Michel S., Tillequin F., Koch M., Pfeiffer B., Renard P., Léonce S., Guilbaud N., Kraus-Berthier L., Atassi Gh., and Pierré A. J. Med. Chem. 43 (2000) 2395-2402
10. Guilbaud N., Léonce S., Tillequin F., Koch M., Hickman J., and Pierré A. Anti-Cancer Drugs 13 (2002) 445-449
11. David-Cordonnier M.-H., Laine W., Lansiaux A., Kouach M., Briand G., Pierré A., Hickman J.A., and Bailly C. Biochemistry 41 (2002) 9911-9920
12. Doan Thi Mai H., Gaslonde T., Michel S., Tillequin F., Koch M., Bongui J.-B., Elomri A., Seguin E., Pfeiffer B., Renard P., David-Cordonnier M.-H., Tardy C., Laine W., Bailly C., Kraus-Berthier L., Léonce S., Hickman J.A., and Pierré A. J. Med. Chem. 46 (2003) 3072-3082
13. David-Cordonnier M.-H., Laine W., Joubert A., Tardy C., Goossens J.-F., Kouach M., Briand G., Doan Thi Mai H., Michel S., Tillequin F., Koch M., Léonce S., Pierré A., and Bailly C. Eur. J. Biochem. 270 (2003) 2848-2859
14. David-Cordonnier M.-H., Laine W., Kouach M., Briand G., Vézin H., Gaslonde T., Michel S., Doan Thi Mai H., Tillequin F., Koch M., Léonce S., Pierré A., and Bailly C. Bioorg. Med. Chem. 12 (2004) 23-29
15. David-Cordonnier M.-H., Laine W., Lansiaux A., Rosu F., Colson P., De Pauw E., Tillequin F., Michel S., Koch M., Pierré A., Hickman J.A., and Bailly C. Mol. Cancer Ther. 4 (2005) 71-80
16. Léonce S., Perez V., Lambel S., Peyroulan D., Tillequin F., Michel S., Koch M., Pfeiffer B., Atassi Gh., Hickman J.A., and Pierré A. Mol. Pharmacol. 60 (2001) 1383-1391
17. Michel S., Seguin E., and Tillequin F. Curr. Med. Chem. 9 (2002) 1241-1253
18. Michel S., Gaslonde T., and Tillequin F. Eur. J. Med. Chem. 39 (2004) 649-655
19. Doan Thi Mai H., Gaslonde T., Michel S., Koch M., Tillequin F., Bailly C., David-Cordonnier M.-H., Pfeiffer B., Renard P., Kraus-Berthier L., Léonce S., and Pierré A. Chem. Pharm. Bull. 53 (2005) 919-922
20. Reisch J., Kamal G.M., and Gunaherath B. J. Chem. Soc., Perkin Trans. I (1989) 1047-1051
21. Mitaku S., Skaltsounis A.-L., Tillequin F., Koch M., Pusset J., and Chauvière G. Heterocycles 26 (1987) 2057-2063
22. Magiatis P., Mitaku S., Skaltsounis A.-L., Tillequin F., Pierré A., and Atassi Gh. Nat. Prod. Lett. 14 (2000) 183-190
23. Lehmstedt K., and Schrader K. Ber. Dtsch. Chem. Ges. 70B (1937) 838-849
24. Valenti P., Borraccini A., Da Re P., and Cima L. Eur. J. Med. Chem. 10 (1975) 387-389
25. Kaltenbronn J.S., Scherrer R.A., Short F.W., Jones E.M., Beatty H.R., Saka M.M., Winder C.V., Wax J., and Williamson W.R.N. Arzneim. Forsch. 33 (1983) 621-627
26. Loughead D.G. J. Org. Chem. 55 (1990) 2245-2246
27. Elomri A., Michel S., Koch M., Seguin E., Tillequin F., Pierré A., and Atassi Gh. Chem. Pharm. Bull. 47 (1999) 1604-1606
28. Nicolaou K.C., Pfefferkorn J.A., Roecker A.J., Cao G.-Q., Barluenga S., and Mitchell H.J. J. Am. Chem. Soc. 122 (2000) 9939-9953
29. Prado S., Ledeit H., Michel S., Koch M., Darbord J.C., Cole S.T., Tillequin F., and Brodin P. Bioorg. Med. Chem. 14 (2006) 5223-5228
30. Li L., Wang H.-K., Chang J.-J., McPhail A.T., McPhail D.R., Terada H., Konoshima T., Kokumai M., Kozuka M., Estes J.R., and Lee K.-H. J. Nat. Prod. 56 (1993) 690-698
31. Yang Z.-Y., Xia Y., Xia P., Tachibana Y., Bastow K.F., and Lee K.-H. Bioorg. Med. Chem. 9 (1999) 713-716
32. Cao S.-G., Wu X.-H., Sim K.-Y., Tan B.H.K., Vittal J.J., Pereira J.T., and Goh S.-H. Helv. Chim. Acta 81 (1998) 1404-1416
33. Wuerzberger S.M., Pink J.J., Planchon S.M., Byers K.L., Bornmann W.G., and Boothman D.A. Cancer Res. 58 (1998) 1876-1885
34. Pierré A., Kraus-Berthier L., Atassi Gh., Cros S., Poupon M.-F., Lavielle G., Berlion M., and Bizarri J.-P. Cancer Res. 51 (1991) 2312-2318